EUVIMEDEUVIMED entdecken
Crossref

Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25‐6981, increases glutamate neurotransmission and induces antidepressant‐like effects

Julie Doan, Céline Defaix, Indira Mendez-David, Alain M Gardier, Romain Colle, Emmanuelle Corruble, Josephine C McGowan, Denis J David, Jean-Philippe Guilloux, Laurent Tritschler iD

Fundamental & Clinical Pharmacology · 2023

DOI: 10.1111/fcp.12917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2023. Verfasst von Julie Doan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Faculté de Pharmacie, UMR 1018 CESP, INSERM MOODS Team, Orsay, France. Hauptthemen laut MEDLINE: Fluoxetine, Major Depressive Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (MENESR, Paris, France).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a serious public health problem, as it is the most common psychiatric disorder worldwide. Antidepressant drugs increase adult hippocampal neurogenesis, which is required to induce some behavioral effects of antidepressants. Adult‐born granule cells in the dentate gyrus (DG) and the glutamate receptors subunits 2 (GluN2B) subunit of N ‐methyl‐D‐aspartate (NMDA) ionotropic receptors play an important role in these effects. However, the precise neurochemical role of the GluN2B subunit of the NMDA receptor on adult‐born GCs for antidepressant‐like effects has yet to be elucidated. The present study aims to explore the contribution of the GluN2B‐containing NMDA receptors in the ventral dentate gyrus (vDG) to the antidepressant drug treatment using a pharmacological approach. Thus, (α R )‐(4‐hydroxyphenyl)‐(β S )‐methyl‐4‐(phenylmethyl)‐1‐piperidinepropanol (Ro25‐6981), a selective antagonist of the GluN2B subunit, was acutely administered locally into the ventral DG (vDG, 1 μg each side) following a chronic fluoxetine (18 mg/kg/day) treatment—known to increase adult hippocampal neurogenesis—in a mouse model of anxiety/depression. Responses in a neurogenesis‐dependent task, the novelty suppressed feeding (NSF), and neurochemical consequences on extracellular glutamate and gamma‐aminobutyric acid (GABA) levels in the vDG were measured. Here, we show a rapid‐acting antidepressant‐like effect of local Ro25‐6981 administration in the NSF independent of fluoxetine treatment. Furthermore, we revealed a fluoxetine‐independent increase in the glutamatergic transmission in the vDG. Our results suggest behavioral and neurochemical effects of GluN2B subunit independent of serotonin reuptake inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineMajor Depressive DisorderHumansMiceAnimalsReceptors, N-Methyl-D-AspartateGlutamic AcidExcitatory Amino Acid AntagonistsAntidepressive AgentsSynaptic Transmission

Stichwörter der Autor:innen

GluN2BNMDARo25-6981antidepressanthippocampus

Substanzen

FluoxetineReceptors, N-Methyl-D-AspartateGlutamic AcidExcitatory Amino Acid AntagonistsAntidepressive Agents

Autor:innen und Institutionen

  • Université Paris-Saclay, Faculté de Pharmacie, UMR 1018 CESP, INSERM MOODS Team, Orsay, France.
  • Université Paris-Saclay, Faculté de Médecine, UMR 1018 CESP, INSERM MOODS Team, Le Kremlin Bicêtre, France.
  • Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
  • Doctoral Program in Neurobiology and Behavior, Columbia University, New York, New York, USA.

ORCID-Profile: Laurent Tritschler

Förderung

  • Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (MENESR, Paris, France)

Zitieren

APA

Doan, J., Defaix, C., Mendez-David, I., Gardier, A. M., Colle, R., Corruble, E., McGowan, J. C., David, D. J., Guilloux, J. P., & Tritschler, L. (2023). Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25‐6981, increases glutamate neurotransmission and induces antidepressant‐like effects. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.12917

Vancouver

Doan J, Defaix C, Mendez-David I, Gardier AM, Colle R, Corruble E, et al. Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25‐6981, increases glutamate neurotransmission and induces antidepressant‐like effects. Fundamental & Clinical Pharmacology. 2023. doi:10.1111/fcp.12917

BibTeX
@article{Doan2023,
  author = {Doan, Julie and Defaix, Céline and Mendez-David, Indira and Gardier, Alain M and Colle, Romain and Corruble, Emmanuelle and McGowan, Josephine C and David, Denis J and Guilloux, Jean-Philippe and Tritschler, Laurent},
  title = {Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25‐6981, increases glutamate neurotransmission and induces antidepressant‐like effects},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2023},
  doi = {10.1111/fcp.12917}
}
Kostenlos starten →